A new drug has shown potential to drastically decrease pain and opioid use for at least one week for patients who have undergone a bunionectomy, according to clinical trial results set to be published in the August 2024 issue of Anesthesiology.
Non-opioid pain drug shows promise in phase 2 trial: Study
